Product correctly added to cart.

discount label
IGFBP4 antibody
View 3D

Biosynth logo

IGFBP4 antibody

Ref. 3D-10-7921

500µg
603.00 €
Estimated delivery in United States, on Tuesday 28 May 2024

Product Information

Name:
IGFBP4 antibody
Description:

The IGFBP4 antibody is a monoclonal antibody that specifically targets and binds to insulin-like growth factor-binding protein 4 (IGFBP4). This antibody has been extensively studied in the field of life sciences and has shown promising results in various research areas.

One of the key characteristics of the IGFBP4 antibody is its ability to inhibit the activity of IGFBP4, a protein involved in regulating the actions of insulin-like growth factors (IGFs). By binding to IGFBP4, this antibody prevents it from interacting with IGFs, thereby modulating their signaling pathways and biological activities.

Furthermore, the IGFBP4 antibody has been found to have potential therapeutic applications. It has been shown to exhibit anti-beta amyloid properties, which may be beneficial in the treatment of neurodegenerative disorders such as Alzheimer's disease. Additionally, this antibody has been investigated for its potential role in targeting steroid receptors and modulating hormone-related processes.

The versatility of the IG

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-10-7921 IGFBP4 antibody

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".